XNCR Competitors & Alternatives
Compare Xencor Inc with similar stocks in the same industry
Biotechnology
XNCR
Main Stock$35.61
-3.99%
Tradestie Score
30
Market Cap
$843.75M
Revenue Growth
454.9%
Analyst Upside
+19.3%
Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)
Bottleneck Score: 2/10
Drug Discovery Biotech
Drug Design
Top Competitors
216 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SLNO
Soleno Therapeutics, Inc. Common Stock
|
$53.01
+0.04%
|
$3.20B | 27.5 | 48 | Compare |
|
MLYS
Mineralys Therapeutics, Inc. Common Stock
|
$14.74
-3.85%
|
$3.09B | - | 59 | Compare |
|
VKTX
Viking Therapeutics, Inc
|
$26.86
-8.08%
|
$3.08B | - | 39 | Compare |
|
CNTA
Centessa Pharmaceuticals plc American Depositary Shares
|
$40.50
+0.80%
|
$3.03B | - | 48 | Compare |
|
XENE
Xenon Pharmaceuticals Inc
|
$39.31
-2.90%
|
$3.02B | - | 33 | Compare |
|
CGON
CG Oncology, Inc. Common stock
|
$84.94
+14.16%
|
$3.01B | - | 34 | Compare |
|
APLS
Apellis Pharmaceuticals, Inc. Common Stock
|
$41.03
-0.07%
|
$2.92B | 38.3 | 50 | Compare |
|
RARE
Ultragenyx Pharmaceutical Inc.
|
$15.96
-0.78%
|
$2.89B | - | 42 | Compare |
|
IMVT
Immunovant, Inc. Common Stock
|
$33.31
-2.56%
|
$2.85B | - | 34 | Compare |
|
CPRX
Catalyst Pharmaceutical Inc.
|
$31.49
+0.03%
|
$2.56B | 18.2 | 51 | Compare |
More XNCR Analysis
Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC 2834)
216 stocks in this industry